Join us for a practical discussion of the US Food and Drug Administration's (FDA’s) latest approach to regulating digital health technologies, including wearable devices, clinical decision support (CDS) software and AI-enabled tools.
This webinar will explore key regulatory distinctions between medical devices and general wellness products, recent FDA guidance updates and compliance considerations for developers, manufacturers and healthcare stakeholders. Attendees will also gain insight into the evolving framework for sensor-based digital health technologies, such as smartwatches, rings, patches and other wearable monitoring devices.
CLE
This course is pending CLE for 1.0 hour of general CLE in AZ, CA, GA, NJ, NY, OH and PA. If you require another jurisdiction, please contact our legal training manager, Robin Hallagan.
If you have any questions about the webinar, please contact Caitlin Murphy.
Our people
About this event
Event type
Webinar
When
18 November 2026
2 – 3 p.m. ET
Please note, registration for the webinar is being handled by Lexology
Where
Want to know more about our events?
Stay informed about new events, webinars, and networking opportunities by joining our mailing list.